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Abstract
Introduction: The use of five fluorouracil (5 FU) as antifibrotic started in the 1960s, in the
hands of ophthalmologists, to prevent adherence after glaucoma and pterigion surgery.
In 1999, Fitzpatrick presented his experience in keloids and hypertrophic scars, making a
great contribution to their treatment. Fibroblasts’ main function is collagen synthesis; in
vicious scar the amount of collagen is normal, but what is altered is the ratio between col‐
lagen subtypes. The use of triamcinolone, the previous standard treatment, produced dif‐
ferent degrees of atrophy and telangiectasias.
Technique: Infiltration is done in the center of fibrosis, weekly for the first month, then
every 15 days until reaching the desired result. Softening, loss of volume and retraction
are seen since the first session. Also pain and itching disappears.
Histopathology: Biopsy of treated scars has organized collagen fibers and less fibroblasts
compared to nontreated scars.
Clinical applications: hypertrophic scars or keloids fixed to deep planes, “supratip”
post-rhinoplasty fibrosis, post-rhinoplasty fibrosis (as preparation for other treatments),
foreign body granulomas, and post-burn retractions. The use in supratip deformity when
secondary to rhinoplasty fibrotic scar has proven very effective, and also as preparation
for surgical (secondary rhinoplasty) and nonsurgical (bioplasty) procedures.
Conclusion: Our experience in the treatment of nasal scars, fibrosis, and retraction with 5
FU is favorable. The results of infiltration with 5FU, hyaluronidase and triamcinolone in
low dose have clinical and histological demonstration of collagen synthesis reduction and
reorganization of collagen cicatrizal fibers.
Keywords: Corticosteroids, fibrosis, fibrosis histopathology, fibrosis treatment, five fluo‐
rouracil, fibroblasts, foreign body granulomas, healing, hyaluronidase, hypertrophic scar,
keloids, nasal aesthetics, nasal dermatology, nasal deformity, nasal reconstruction, post-
rhinoplasty fibrosis, burn sequelae, scar, scarring disorders, supratip deformity
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1. Introduction
Since Fitzpatrick [1] published his work with five fluorouracil (5FU) in 1999, we included it in
our daily practice. The most frequent use of this drug is for treatment and prevention of
hypertrophic scars, keloids, and foreign body granulomas [2].
The particular anatomy of the skin in each nasal subunit makes scarring process completely
different among them (Fig. 1). The skin of the tip is thick, has follicular units, and sebaceous
glands, whereas the dorsum skin is thin with almost no subcutaneous tissue. Because of these,
the nasal tip skin reacts violently to injury, with an important inflammatory process and
residual edema that generates unaesthetic deformities. The dorsum skin reacts softly to
injuries, with light inflammation and scarring, but strong adherence to deep structures due to






Figure 1. Anatomical structure of nasal tip and dorsum.
Fibroblasts’ proliferation and migration play a major role in wound healing. Their main
metabolic function is collagen, elastin, and proteoglycans synthesis. Fibroblasts’ suppression
in hypertrophic scars and keloids is essential since collagen synthesis is increased by 14% and
20%, respectively, compared to normal skin. Other studies show a higher amount of fibroblasts
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without significant increase in collagen synthesis but with altered proportions between
collagen I, III, and IV. These studies also show an increased production of fibronectin by
fibroblasts. The local increase of collagenase inhibitors has also been reported.
Local steroids have been the gold standard treatment for nasal inflammatory and fibrotic
processes for years, but its use has important side effects and complications. Triamcinolone
usually generates different grades of skin atrophy and telangiectasias in the nasal tip and ala.
5 FU is a citostatic antimetabolite drug that inhibits cell proliferation by:
• Inhibition of thymidylate synthase avoiding DNA synthesis
• Incorporation in RNA and DNA altering its function
• Interference with glycosyltransferases altering cell membranes (Fig. 2)
Figure 2. Molecular structure of 5 FU.
It has been proved in laboratory tests that 5 FU produces a slight reduction of collagen synthesis
in normal fibroblasts but a drastic reduction in altered ones, as in Dupuytren illness [3].
Apparently, it also inhibits the collagen synthesis stimulation effect of TGF1 (transforming
growth factor).
5 FU has been used for years in treatment of premalignant and malignant lesions of skin and
mucosa due to its selective toxicity for dysplastic epithelium and fibroblasts. The first appli‐
cation of 5 FU was as an antifibrotic to prevent fibrous scarring after glaucoma surgery and to
avoid relapse in pterigion surgery in the 1960s [4, 5, 6, 7, 8, 9]. In February of 1999, its use was
reported to prevent fibrous adherence after tendon reconstructive surgery. One month after
Fitzpatrick published his 7-year experience of over a thousand patients with 5 FU in hyper‐
trophic scars and keloids. This magnificent work encouraged our team to include it in our
office with positive results. Since Lambros published his work in 2004 [10], our team also added
hyaluronidase. This last is an enzyme that increases connective tissue permeability by
hyaluronic acid hydrolysis. Hyaluronic acid is a polysaccharide of connective tissue and other
specialized tissues as the umbilical cord and the vitreous humor. Hydrolysis is done between
the C1of glucosamine and C4 of glucuronic acid. This reduces temporarily the intercellular
cement viscosity, promoting diffusion of injected solution, exudates, and transudates facili‐
tating absorption.
Five Fluorouracil, Hyaluronidase, and Triamcinolone in the Nasal Region
http://dx.doi.org/10.5772/62068
115
Triamcinolone is a steroid; it diffuses through cell membranes binding with cytoplasmic
receptors that are translocated to the nucleus generating the transcription of proteins that are
responsible for their effects. It reduces tissue response to inflammation, reducing it symptoms
without treating the specific cause. To do this it reduces the white blood cell (WBC) migration
to the affected tissue. The most important effects are:
• Inhibition of phagocytosis
• Inhibition of liberation of lysosomal enzymes and inflammatory mediators
• Reduction of capillary permeability and WBC adhesion to capillary endothelium
• Reduction of blood concentration of T-cells, eosinophils, and monocytes
• Reduction of immunoglobulin binding with cellular receptors
In the past 14 years, we have been using a preparation of 5FU, hyaluronidase, and triamcino‐
lone for the nasal area, and we have not had the complications and side effects observed with
steroids monotreatment.
2. Technique
5 FU (Fluorouracil- Filaxis 500mg) is presented commercially as ampoules of 10 ml containing
50 mg per ml. Triamcinolone (Kenacort-A-BSM) is used in its acetonide form of 40mg/ml and
is commercialized in ampoules of 1ml (Fig. 3). Hyluronidase (Unidasa Roux Ocefa) is com‐
mercialized in ampoules that contain 500 UI of testicular ovine freeze-dried powder hyaluro‐
nidase. We use 2.7 ml of 5 FU and 0.3ml of triamcinolone to reconstitute hyaluronidase (5 FU
solution). For the application, a 0.3 or 0.5 ml Luer lock syringe and 30 G needle are preferred.
This allows a better dosage and correct plane of infiltration. We have never used more that 0.5
ml of the solution in the nasal area per session. The infiltration is done with multiple punctures
in the “heart” of the fibrotic lesion. In the first month, one session is done per week; then it is
spaced to every fifteen days. The improvement is evaluated with three parameters: hardening
reduction, loss of volume, and reduction of cutaneous retraction. Positive changes are observed
since the first session, not only in the above parameters but also in aesthetics and pain–itching
symptomatology. Some cases are complemented with kinesiology treatment in order to obtain
a better functional and cosmetic result.
3. Histopathology
If after finishing the treatment a surgical procedure was needed to improve the result, the
surgical piece was sent to the pathologist and compared to nontreated scarring tissue resec‐
tions. Results informed reduction of fibrosis and rearrangement of collagen tissue in the treated
pieces. These results are illustrated in the images. In the tissue of the right side of the scar
proliferation of fibrous tissue, great amount of fibroblasts and collagen fibers forming tangles
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is seen (Fig. 4). In the tissue of the left, treated with 5 FU solution, there are less fibroblasts,
and the collagen fibers adopt a parallel disposition (Fig. 5).
Figure 4. Microscopic image of fibrosis without any infiltration treatment (left).
Figure 3. Commercial presentations of 5 FU and triamcinolone
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Figure 5. Microscopic image of fibrosis after infiltration with 5 FU (right).
4. Clinical applications
• Hypertrophic scars or keloids fixed to deep planes
• “Supratip” post-rhinoplasty fibrosis
• Post-rhinoplasty fibrosis (as preparation for other treatments)
• Foreign body granulomas
• Post-burn retractions
4.1. Hypertrophic scars or keloids fixed to deep planes
The nose, being a mid-facial and projected structure, is exposed to trauma that leaves scarring
sequels in the skin. Traumatic scarring if healed by second intention generates unaesthetic
scars. The use of 5 FU, triamcinolone, and hyaluronidase for hypertrophic scars and keloids
in the nasal area is in our hands more effective and safe than the use of steroids alone. When
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these scars are fixed to deep planes, the infiltration is done as preparation to subcision and
then a filler as Polymethylmetacrilate (PMMA) is used to prevent the relapse of the adherence
(Figs. 6 and 7).
Figure 6. Nasal tip scar after cartilage graft infection and extrusion. Frontal view before and after 5 FU injection and
dermabration.
4.2. “Supratip” post-rhinoplasty fibrosis
One of the most frequent complications of rhinoplasty is the healing fibrosis that is formed
over time, known as “fibrous supratip.” It can be the result of a badly executed rhinoplasty or
defective healing process. It is very frequent among beginners and even experts still have this
complication. There are many causes of supratip deformity and each demands a specific
treatment. Bahman Guyuron [11] conducted a clinical and histological study to unmask the
surgical causes of this deformity. This study shows that clinical supratip is observed in 9% of
primary and 36% of secondary consults of rhinoplasty. In primary cases, the deformity is the
result of: tip inadequate projection, caudal dorsum overprojection, lateral inferior cartilages
cephalic orientation, or a combination of these. In secondary cases, the deformity is the result
of: subcorrection or overcorrection of caudal dorsum, overresection of medial valve, subpro‐
jected tip, or a combination of these. The histophatological study of the supratip soft tissue
demonstrated significant fibrosis in 14 of 16 secondary patients and 13 of 23 primary patients.
The supratip deformity can be avoided through appropriate resection of caudal dorsum (in
order not to leave dead space), nasal tip projection, and joining with stitches the subcutaneous
tissue over the cartilages in the supratip area. When diagnosed early, if the tip has adequate
projection and the supratip tissue can be collapsed by pressure, the elective treatment is
compressive tape. If after 6 weeks the response is not positive, 0.2–0.4 ml of 5 FU solution is
injected in the deep (Figs. 8 and 9) subcutaneous tissue. This infiltration can be repeated
monthly until reaching the desired result. (The judicious use of 5 FU solution can help in most
supratip deformities caused by fibrosis when the caudal septum and the tip cartilages are
strong. If the cartilaginous frame is weak, infiltration will not solve the problem.)
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Figure 7. Nasal tip scar after cartilage graft infection and extrusion. Lateral view before and after 5 FU injection and
dermabration.
Figure 8. Fibrose supratip after previous procedure solve after 5 year with 0.3 ml of 5 FU single injection. Frontal view.
Infiltration can reduce a big supratip to a small one but with an important risk of skin atrophy.
Other authors such as Gruber [12] prefer to start with infiltration after 4–6 weeks of surgery,
when most edema has disappeared. He uses 1–2 mg of triamcinolone (0.1–0.2 cc of triamcino‐
lone 10 mg/cc) in the supratip or other fibrous area. Pastorek [13] uses small steroids doses
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during and immediately after surgery, having excellent results in his hands. If a severe supratip
deformity is the consequence of inadequate cartilage resection or subprojection of the tip, a
surgical correction or bioplasty is needed. Sheen [14] suggested in 1979 that most supratip
deformities were caused by caudal dorsum overresection. He proposed then the use of
cartilage graft to correct this deformity.
Figure 9. Fibrose supratip after previous procedure solved after 5 years with 0.3 ml of 5 FU single injection. Frontal
view. Lateral view.
Figure 10. Patient with 3 previous rhinoplasties. Three applications of 5 FU solution were done.
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Nowadays, it is widely accepted that healing fibrotic tissue formed to fill the dead space is the
most frequent cause of supratip deformity post-rhinoplasty. But it was not until Guyuron’s
work that this was scientifically confirmed.
4.3. Post-rhinoplasty fibrosis, as preparation for other treatments
After several surgical procedures, the nose can be involved in different grades of fibrosis,
turning the skin hard and inelastic. Before performing a secondary rhinoplasty or a bioplasty,
we prefer preparing the area with some applications of the 5 FU solution, in order to soften
the tissue (Fig. 10).
4.4. Foreign body granulomas
The use of fillers in the nasal area is a very popular method to correct slight deformities. There
are many different materials and each of them produces a different degree of fibrotic reaction
in the tissue. In most cases, this is a controlled reaction and leads to the expected result. But in
some cases, an overreaction of patient immune system, bad application technique, or the
chemistry of the material used provoke the formation of foreign body granulomas, resulting
in unaesthetic deformities.
The use of triamcinolone in these cases can generate skin atrophy, thus turning the deformity
more visible. When the filler used is hyaluronic acid, pure hyaluronidase should be infiltrated
as stated by Brody [15] and Hirsch [16]. Infiltration is done with 100 UI in the area of hyaluronic
acid excess (Fig. 11). This dissolves the acid, solving the fibrosis. When alloplastic materials
were used, we preferred the 5 FU solution for infiltration because it does not have the side
effects of steroids monotreatment. The application has a double effect, the pharmacological
effect of the drugs, and the mechanical effect of disruption by the fluid pressure.
4.5. Post-burn retractions
The nasal skin usually gets affected in facial burns. The scarring retraction can deform the tip,
ala, or both, stretching the nostrils. We use the 5 FU solution infiltration in these fibrous areas
in order to increase the tissue elasticity and prepare them for secondary procedures as PMMA
bioplasty or compound auricular graft.
5. Complications
The use of 5 FU solution, in young patients mostly, can cause tissue necrosis. This is relatively
frequent in keloid treatment, resulting in ulcers or brown stains in the application spots.
However, in the nasal region we have not observed this complication, mainly because of the
low dosage. In this way, by using a progressive treatment instead of an aggressive one, side
effects are kept to the minimum.
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6. Conclusions
Through this chapter, we have presented our experience in the treatment of scars, fibrosis,
retractions, and deformities over the nasal skin. The results of our 14-year experience with 5
FU solution (5 FU, triamcinolone, and hyaluronidase) have the histopathological demonstra‐
tion of effectiveness in collagen fibers synthesis reduction and fiber rearrangement, thus
explaining the positive clinical effect.
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